Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

259 Views

149. HIV: Prevention: Friday, 12:15 - 1:30 p.m.

Poster Session: HIV: Prevention

(1559) Healthcare Staff Perceptions of Feasibility and Acceptability on Implementing Injectable HIV Pre-exposure Prophylaxis into Standard of Care: Baseline Results from the PrEP Implementation Study for Cabotegravir Long Acting for Men in the Real World (PILLAR)

Friday, October 13, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Julian A. Torres, MD (he/him/his)

Associate Professor
Montefiore Medical Center, Albert Einstein College of Medicine
Bronx, New York, United States

Dima Dandachi, MD, MPH (she/her/hers)

Assistant Professor of Medicine
University of Missouri - Columbia
Columbia, Missouri, United States
HH

Hadrian Holder, MD

Southwest Community Health Center
Bridgeport, Connecticut, United States
BL

Bo Li, PhD

GSK
Collegeville, Pennsylvania, United States
AG

Alison Gaudion, PhD

ViiV Healthcare
Brentford, England, United Kingdom
DM

Deanna Merrill, PharmD, MBA, AAHIVP

Medical Affairs Scientific Director, Research
ViiV Healthcare
Research Triangle Park, North Carolina, United States
DA

David Andrae, PhD

Evidera Inc.
Bethesda, Maryland, United States
WL

William Lenderking, PhD

Evidera Inc.
Bethesda, Maryland, United States
RM

Riya Moodley, FCP

ViiV Healthcare
Brentford, England, United Kingdom
Ad

Annemiek de Ruiter, MBBS FRCP

Head of Global Medical Sciences
ViiV Healthcare.
London, England, United Kingdom
Maggie Czarnogorski, MD MPH

Head, Innovation and Implementation Science
ViiV Healthcare
Research Triangle Park, NC, United States
NP

Nanlesta Pilgrim, PhD

ViiV Healthcare
Durham, North Carolina, United States